HK1249851A1 - 使用聚維酮碘的普通感冒的治療和預防 - Google Patents

使用聚維酮碘的普通感冒的治療和預防

Info

Publication number
HK1249851A1
HK1249851A1 HK18109282.8A HK18109282A HK1249851A1 HK 1249851 A1 HK1249851 A1 HK 1249851A1 HK 18109282 A HK18109282 A HK 18109282A HK 1249851 A1 HK1249851 A1 HK 1249851A1
Authority
HK
Hong Kong
Prior art keywords
povidone
iodine
prevention
treatment
common cold
Prior art date
Application number
HK18109282.8A
Other languages
English (en)
Inventor
Stephen Goodall
Peter Molloy
Original Assignee
Firebrick Pharma Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2014206143A external-priority patent/AU2014206143C1/en
Application filed by Firebrick Pharma Pty Ltd filed Critical Firebrick Pharma Pty Ltd
Publication of HK1249851A1 publication Critical patent/HK1249851A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18109282.8A 2014-07-23 2018-07-18 使用聚維酮碘的普通感冒的治療和預防 HK1249851A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2014206143A AU2014206143C1 (en) 2014-07-23 Treatment and prevention of the common cold using povidone-iodine

Publications (1)

Publication Number Publication Date
HK1249851A1 true HK1249851A1 (zh) 2018-11-16

Family

ID=51794584

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18109282.8A HK1249851A1 (zh) 2014-07-23 2018-07-18 使用聚維酮碘的普通感冒的治療和預防

Country Status (18)

Country Link
US (2) US11000542B2 (zh)
EP (2) EP3326635B1 (zh)
JP (2) JP2017522330A (zh)
CN (1) CN106794198A (zh)
AU (2) AU2015292256B2 (zh)
CA (1) CA2955982C (zh)
DK (1) DK3326635T3 (zh)
ES (1) ES2895429T3 (zh)
HK (1) HK1249851A1 (zh)
HR (1) HRP20211810T1 (zh)
HU (1) HUE056533T2 (zh)
MY (1) MY189342A (zh)
NZ (1) NZ728284A (zh)
PH (1) PH12017500135A1 (zh)
PL (1) PL3326635T3 (zh)
PT (1) PT3326635T (zh)
SG (2) SG11201700286XA (zh)
WO (1) WO2016011496A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017522330A (ja) 2014-07-23 2017-08-10 ファイアブリック・ファーマ・ピー・ティー・ワイ．エル・ティー・ディーＦｉｒｅｂｒｉｃｋ Ｐｈａｒｍａ Ｐｔｙ Ｌｔｄ ポビドンヨードを使用した感冒の治療および予防
CA3141483A1 (en) * 2019-06-10 2020-11-26 Firebrick Pharma Limited Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes
CN114269354A (zh) * 2019-08-30 2022-04-01 3M创新有限公司 应用消毒剂组合物进行病毒的传播预防
CN113244263A (zh) * 2020-02-07 2021-08-13 北京天衡军威医药技术开发有限公司 一种用于预防及治疗呼吸道感染性疾病的雾化吸入制剂
CN113244262A (zh) * 2020-02-07 2021-08-13 北京天衡军威医药技术开发有限公司 一种用于预防及治疗呼吸道感染性疾病的吸入粉雾制剂
WO2022099182A1 (en) * 2020-11-09 2022-05-12 Rucker Capital Advisors Oral rinse, nasal spray and methods for prevention of covid-19 by lowering viral load of covid-19

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3028300A (en) 1960-09-13 1962-04-03 West Laboratories Inc Germicidal compositions and methods for preparing the same
US5038769A (en) 1983-06-29 1991-08-13 Krauser Robert S Method and apparatus for treating ailments
US4523589A (en) * 1983-06-29 1985-06-18 Krauser Robert S Method and apparatus for treating ailments
US6171611B1 (en) 1997-11-12 2001-01-09 Dante J. Picciano Iodine-containing nasal moisturizing saline and mouthwash solutions
JPH11228387A (ja) * 1998-02-05 1999-08-24 Taisho Pharmaceut Co Ltd ヨード系殺菌剤を含有する薬用組成物
JP4741727B2 (ja) 1998-05-27 2011-08-10 ユーロ−セルティーク エス．エイ． 抗炎症剤、特に消毒剤及び／又は創傷治癒促進剤を下気道に適用するための製剤
US7297344B1 (en) 1999-05-27 2007-11-20 Euro-Celtique, S.A. Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
US6694041B1 (en) 2000-10-11 2004-02-17 Digimarc Corporation Halftone watermarking and related applications
US6696041B2 (en) * 2002-03-20 2004-02-24 Richard L. Hansen Treatment of colds, flu like infections and other general nasal based infections with a solution containing iodine and other broad spectrum microbicides and a method for its use
US8679462B2 (en) 2002-04-11 2014-03-25 Saeed Rezakhany Methods of preventing respiratory infections
JP2004352642A (ja) 2003-05-29 2004-12-16 Meiji Seika Kaisha Ltd ウイルス感染症予防剤
CA2537059A1 (en) * 2003-08-28 2005-05-12 Pure Bioscience Anhydrous silver dihydrogen citrate compositions
ES2310790T3 (es) * 2004-10-13 2009-01-16 The Procter And Gamble Company Dispositivo para suministrar una composicion antimicrobiana.
US20080138438A1 (en) * 2004-12-09 2008-06-12 The Dial Cprporation Compositions Having A High Antiviral And Antibacterial Efficacy
WO2007044032A2 (en) * 2004-12-09 2007-04-19 The Dial Corporation Compositions having a high antiviral and antibacterial efficacy
US20060280809A1 (en) 2005-06-14 2006-12-14 Leshchiner Adele K Anti-infective iodine based compositions for otic and nasal use
US8303994B2 (en) 2006-06-22 2012-11-06 Jack Howard Kessler Method for the eradication of pathogens including S. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells
WO2012177251A1 (en) * 2011-06-22 2012-12-27 Adeda Therapeutics Company Limited Pharmaceutical compositions comprising iodine and steroid and uses thereof for sinus diseases
CN103751274B (zh) 2014-02-20 2016-08-17 河北旺达饲料兽药开发有限公司 一种治疗鸭、鹅黄病毒感染的药物组合物及其制备方法
JP2017522330A (ja) 2014-07-23 2017-08-10 ファイアブリック・ファーマ・ピー・ティー・ワイ．エル・ティー・ディーＦｉｒｅｂｒｉｃｋ Ｐｈａｒｍａ Ｐｔｙ Ｌｔｄ ポビドンヨードを使用した感冒の治療および予防
KR20170033925A (ko) 2015-09-17 2017-03-28 송경진 항바이러스 및 세균용 스프레이 조성물
KR101935250B1 (ko) 2017-07-04 2019-01-04 김대황 요오드제 및 삼투성 미각제를 포함하는 눈, 구강용, 비강용 또는 흡입용 항바이러스 및 항균 조성물

Also Published As

Publication number Publication date
AU2014206143B1 (en) 2014-10-23
SG11201700286XA (en) 2017-02-27
US11000542B2 (en) 2021-05-11
JP2017522330A (ja) 2017-08-10
AU2019100465B4 (en) 2020-06-18
EP3326635A1 (en) 2018-05-30
PT3326635T (pt) 2021-11-04
PH12017500135B1 (en) 2017-05-29
ES2895429T3 (es) 2022-02-21
AU2015292256A1 (en) 2017-06-15
HUE056533T2 (hu) 2022-02-28
PH12017500135A1 (en) 2017-05-29
CN106794198A (zh) 2017-05-31
MY189342A (en) 2022-02-04
EP3326635B1 (en) 2021-09-01
WO2016011496A1 (en) 2016-01-28
HRP20211810T1 (hr) 2022-03-04
AU2015292256B2 (en) 2020-09-17
JP2021059553A (ja) 2021-04-15
NZ728284A (en) 2020-07-31
CA2955982C (en) 2023-09-05
EP3171881A4 (en) 2018-01-10
DK3326635T3 (da) 2021-11-15
AU2019100465A4 (en) 2019-06-06
SG10201900559VA (en) 2019-02-27
EP3171881A1 (en) 2017-05-31
US20170165296A1 (en) 2017-06-15
PL3326635T3 (pl) 2022-02-07
CA2955982A1 (en) 2016-01-28
US20200316109A1 (en) 2020-10-08

Similar Documents

Publication Publication Date Title
ZA201607415B (en) Antibody-drug-conjugate and its use for the treatment of cancer
HK1243073A1 (zh) 治療性化合物及其用途
EP3200915A4 (en) Biochars and biochar treatment processes
GB2554629B8 (en) Prevention and treatment of microbial infections
GB201411496D0 (en) Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy
IL259570A (en) Combined therapy and their uses and methods
EP3334429C0 (en) HYPERPHENYLALANINEMIA AND TREATMENTS THEREFOR
HK1249851A1 (zh) 使用聚維酮碘的普通感冒的治療和預防
LT3558280T (lt) Migrenos profilaktika ir gydymas
EP3107473A4 (en) Treatment devices and realtime indications
GB201404372D0 (en) Assay and treatment
GB201413530D0 (en) Treatment and prevention of malaria
GB201616009D0 (en) Treatment and/or prevention of sepsis
FI3197556T3 (fi) Koostumus allergisten oireiden ennalta ehkäisemiseksi ja/tai hoitamiseksi
HK1209359A1 (zh) 極巨巨單胞菌在治療或預防類風濕性關節炎或其相關疾病中的應用
GB201418809D0 (en) Therapeutic agents and uses thereof
HK1243961A1 (zh) 炎性病况的預防和治療
HK1209369A1 (zh) 沙氏別樣桿菌在治療或預防類風濕性關節炎或其相關疾病中的應用
HK1209367A1 (zh) 系結梭菌在治療或預防類風濕性關節炎或其相關疾病中的應用
AU2014206143C1 (en) Treatment and prevention of the common cold using povidone-iodine
GB201522828D0 (en) Prevention and treatment of glaucoma
GB201420856D0 (en) Prevention and treatment of microbial infections
AU2014903677A0 (en) Treating and/or preventing psoriasis
GB201415876D0 (en) Methods for the treatment and prevention of Ebola
AU2014904752A0 (en) Methods for the treatment and prevention of iron overload